Stocktoria

Victrex plc VCT.L

GB · London Stock Exchange · XLON · stock · Basic Materials · website

Victrex plc (VCT.L) earns a Piotroski F-score of 7/9 (strong financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 7.28% (safety: at-risk). FY2025 revenue was £296.4M at a 9.4% net margin.

£817.00 high · £570.00 low · daily closes (~2y) · hover for date & price
69/100
Stocktoria Quality Score · grade B
7/9
Piotroski F — financial health
7.42
Altman Z″ — distress risk · safe
0.1%
Dividend yield 5y avg · at-risk · Dividend payout 186.3%

Quality score trend · recomputed for each fiscal year

Piotroski F /9
5 5 7 202320242025
Altman Z″
9.02 8.15 7.42 202320242025

Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.

£817.00 as of 2026-08-03 · +14.4% 1y
£570.00£817.0052-wk
Market cap USD$961M
P / E25.6×
Dividend yield 5y avg0.1%
Net margin 5y avg14.4%
Return on equity 5y avg9.5%
Beta0.76
Employees1,169

Analyst price target

£676.29 -17.2% vs last
consensus: buy · 14 analysts
target range £575.00 – £870.00

Wall Street analyst consensus — a sentiment gauge, not our scoring.

Revenue trend · last 4y · down

How it ranks in Basic Materials · percentile among 111 companies

Piotroski Fstronger than 63%
Net marginstronger than 60%
Return on equitystronger than 50%
Revenue growthstronger than 41%

Percentile vs other Basic Materials companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 7/9 tests passed

Altman Z″ components · safe zone

ComponentValue
Working capital / assets0.218
Retained earnings / assets0.662
EBIT / assets0.07
Equity / liabilities3.195

About Victrex plc

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; and sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, aerospace, automotive, and electronics markets, as well as engages in trading activities. It serves automotive, aerospace, energy and industrial, electronics, and medical markets. Victrex plc was incorporated in 1993 and is headquartered in Thornton-Cleveleys, the United Kingdom.

FAQ

Is VCT.L financially healthy?

Victrex plc's Piotroski F-score is 7/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.

Does VCT.L pay a dividend, and is it safe?

Yes. Victrex plc pays a dividend yielding about 7.28% with a 186.3% payout ratio, rated “at-risk” for safety.

How profitable is VCT.L?

In FY2025, Victrex plc had a net margin of 9.4% and a return on equity of 6.4%.

Is VCT.L overvalued or undervalued?

Victrex plc trades at about 2569.2× trailing earnings — above its 10-year norm (10-year range 1893.5×–4324.9×, median 2034.6×). Stocktoria reports the data, not buy/sell advice.

What is the analyst price target for VCT.L?

The average Wall-Street price target for Victrex plc is £676.29, about 17.2% below the recent price, from 14 analysts (consensus: buy).

Is VCT.L a good stock to buy?

Stocktoria doesn't give buy or sell advice, but here is the data on Victrex plc: a Piotroski F-score of 7/9, an Altman Z″ in the safe zone, a P/E of about 25.6×, a dividend yield of 7.28%. Weigh these quality and valuation signals against your own goals.

Computed from company filings · GB · as of 2025-09-30. Figures in GBP. Facts plus Stocktoria's own computed scores — not investment advice.